Exosens SAS [EXENS] vs Nexans S.A [NEX] Detailed Stock Comparison
Exosens SAS
Euronext
Loading...
Nexans S.A
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Exosens SAS wins in 7 metrics, Nexans S.A wins in 11 metrics, with 0 ties. Nexans S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Exosens SAS | Nexans S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 32.85 | 11.87 | Nexans S.A |
| Price-to-Book Ratio | 4.77 | 2.87 | Nexans S.A |
| Debt-to-Equity Ratio | 62.50 | 109.26 | Exosens SAS |
| PEG Ratio | -203.57 | 15.45 | Exosens SAS |
| EV/EBITDA | 22.37 | 6.40 | Nexans S.A |
| Profit Margin (TTM) | 12.91% | 5.29% | Exosens SAS |
| Operating Margin (TTM) | 21.03% | 6.52% | Exosens SAS |
| EBITDA Margin (TTM) | 21.03% | 6.52% | Exosens SAS |
| Return on Equity | 13.73% | 25.68% | Nexans S.A |
| Return on Assets (TTM) | 6.91% | 4.62% | Exosens SAS |
| Free Cash Flow (TTM) | $96.20M | $775.00M | Nexans S.A |
| Dividend Yield | 0.23% | 2.61% | Nexans S.A |
| 1-Year Return | 100.96% | 13.52% | Exosens SAS |
| Price-to-Sales Ratio (TTM) | 4.78 | 0.61 | Nexans S.A |
| Enterprise Value | $2.34B | $5.55B | Nexans S.A |
| EV/Revenue Ratio | 5.42 | 0.62 | Nexans S.A |
| Gross Profit Margin (TTM) | 59.20% | N/A | N/A |
| Revenue per Share (TTM) | $8 | $207 | Nexans S.A |
| Earnings per Share (Diluted) | $1.23 | $10.63 | Nexans S.A |
| Beta (Stock Volatility) | N/A | 1.06 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Exosens SAS vs Nexans S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Exosens SAS | -1.86% | -4.23% | 1.67% | 8.33% | 77.80% | 106.19% |
| Nexans S.A | 1.96% | 7.30% | 27.31% | 36.77% | 46.16% | 29.63% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Exosens SAS | 100.96% | 76.22% | 76.22% | 76.22% | 76.22% | 76.22% |
| Nexans S.A | 13.52% | 38.74% | 180.73% | 257.39% | 371.24% | 371.24% |
Performance & Financial Health Analysis: Exosens SAS vs Nexans S.A
| Metric | EXENS | NEX |
|---|---|---|
| Market Information | ||
| Market Cap | €2.07B | €5.52B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 124,372 | 120,836 |
| 90 Day Avg. Volume | 89,526 | 104,109 |
| Last Close | €39.65 | €135.20 |
| 52 Week Range | €16.84 - €46.60 | €74.40 - €147.00 |
| % from 52W High | -14.91% | -8.03% |
| All-Time High | €46.60 (Jun 04, 2025) | €147.00 (Oct 28, 2024) |
| % from All-Time High | -14.91% | -8.03% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.11% |
| Quarterly Earnings Growth | 8.75% | 1.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.05% |
| Operating Margin (TTM) | 0.21% | 0.07% |
| Return on Equity (TTM) | 0.14% | 0.26% |
| Debt to Equity (MRQ) | 62.50 | 109.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €8.46 | €43.94 |
| Cash per Share (MRQ) | €1.77 | €47.41 |
| Operating Cash Flow (TTM) | €101.11M | €946.00M |
| Levered Free Cash Flow (TTM) | €-18,931,500 | €724.75M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.23% | 2.61% |
| Last 12-Month Dividend | €0.10 | €2.60 |
Valuation & Enterprise Metrics Analysis: Exosens SAS vs Nexans S.A
| Metric | EXENS | NEX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 32.85 | 11.87 |
| Forward P/E | 22.72 | 15.45 |
| PEG Ratio | -203.57 | 15.45 |
| Price to Sales (TTM) | 4.78 | 0.61 |
| Price to Book (MRQ) | 4.77 | 2.87 |
| Market Capitalization | ||
| Market Capitalization | €2.07B | €5.52B |
| Enterprise Value | €2.34B | €5.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.42 | 0.62 |
| Enterprise to EBITDA | 22.37 | 6.40 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.06 |
| Book Value per Share (MRQ) | €8.46 | €43.94 |
Financial Statements Comparison: Exosens SAS vs Nexans S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EXENS | NEX |
|---|---|---|
| Revenue/Sales | €100.21M | N/A |
| Cost of Goods Sold | €40.89M | N/A |
| Gross Profit | €59.32M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | €21.16M | N/A |
| EBITDA | €30.76M | N/A |
| Pre-Tax Income | €284,000 | N/A |
| Income Tax | €914,000 | N/A |
| Net Income (Profit) | €-630,000 | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EXENS | NEX |
|---|---|---|
| Cash & Equivalents | €123.17M | €1.25B |
| Total Current Assets | €315.86M | €4.33B |
| Total Current Liabilities | €111.74M | €3.62B |
| Long-Term Debt | €254.15M | €1.71B |
| Total Shareholders Equity | €381.98M | €1.83B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | €53.37M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EXENS | NEX |
|---|---|---|
| Operating Cash Flow | €20.46M | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | €13.18M | N/A |
| Debt Repayment | €-307.62M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EXENS | NEX |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 124,372 | 120,836 |
| Average Daily Volume (90 Day) | 89,526 | 104,109 |
| Shares Outstanding | 50.76M | 43.60M |
| Float Shares | 29.78M | 33.54M |
| % Held by Insiders | 0.34% | 0.17% |
| % Held by Institutions | 0.44% | 0.52% |
Dividend Analysis & Yield Comparison: Exosens SAS vs Nexans S.A
| Metric | EXENS | NEX |
|---|---|---|
| Last 12-Month Dividend | €0.10 | €2.60 |
| Last 12-Month Dividend Yield | 0.23% | 2.61% |
| 3-Year Avg Annual Dividend | €0.03 | €2.33 |
| 3-Year Avg Dividend Yield | 0.23% | 2.47% |
| 3-Year Total Dividends | €0.10 | €7.00 |
| Ex-Dividend Date | May 28, 2025 | May 19, 2025 |